(MS) Morgan Stanley - Overview
Sector: Financial Services | Industry: Capital Markets | Exchange: NYSE (USA) | Market Cap: 299.022m USD | Total Return: 56.9% in 12m
Industry Rotation: -18.2
Avg Turnover: 941M
EPS Trend: 97.1%
Qual. Beats: 3
Rev. Trend: 98.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Morgan Stanley is a global financial services holding company headquartered in New York. The firm operates through three primary segments: Institutional Securities, Wealth Management, and Investment Management. Its core business includes investment banking, sales and trading, financial advisory, and asset management services for a diverse client base of corporations, governments, and individuals.
The company functions within the Investment Banking & Brokerage sub-industry, where revenue is traditionally driven by advisory fees, underwriting spreads, and net interest income from lending operations. In recent years, the firm has strategically shifted its business model toward Wealth Management to increase its proportion of fee-based, recurring revenue, which typically offers lower volatility than institutional trading and investment banking.
Investors can further evaluate these revenue streams and historical performance trends on ValueRay.
Beyond capital markets, Morgan Stanley provides extensive banking services, including residential real estate loans and commercial lending. Its global footprint allows it to capture deal flow across the Americas, EMEA, and Asia, leveraging its research and prime brokerage divisions to support institutional liquidity and market-making activities.
- Net interest income sensitivity to Federal Reserve monetary policy shifts
- Wealth management asset inflows drive recurring fee-based revenue growth
- Investment banking activity levels dictate advisory and underwriting fee volatility
- Regulatory capital requirements influence share buyback and dividend capacity
- Global equity market performance impacts institutional trading and brokerage commissions
| Net Income: 18.18b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 2.27 > 1.0 |
| NWC/Revenue: 340.5% < 20% (prev -596.7%; Δ 937.2% < -1%) |
| CFO/TA -0.00 > 3% & CFO -1.01b > Net Income 18.18b |
| Net Debt (-265.51b) to EBITDA (27.21b): -9.76 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.59b) vs 12m ago -0.44% < -2% |
| Gross Margin: 57.99% > 18% (prev 0.56%; Δ 5.74k% > 0.5%) |
| Asset Turnover: 8.34% > 50% (prev 8.13%; Δ 0.21% > 0%) |
| Interest Coverage Ratio: 0.33 > 6 (EBITDA TTM 27.21b / Interest Expense TTM 50.19b) |
| A: 0.26 (Total Current Assets 1075.79b - Total Current Liabilities 666.50b) / Total Assets 1581.42b |
| B: 0.08 (Retained Earnings 118.91b / Total Assets 1581.42b) |
| C: 0.01 (EBIT TTM 16.41b / Avg Total Assets 1440.86b) |
| D: 0.08 (Book Value of Equity 113.43b / Total Liabilities 1466.03b) |
| Altman-Z'' Score: 2.10 = BBB |
| DSRI: 1.27 (Receivables 132.60b/92.15b, Revenue 120.22b/105.71b) |
| GMI: 0.97 (GM 57.99% / 56.30%) |
| AQI: 0.37 (AQ_t 0.32 / AQ_t-1 0.86) |
| SGI: 1.14 (Revenue 120.22b / 105.71b) |
| TATA: 0.01 (NI 18.18b - CFO -1.01b) / TA 1581.42b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
Over the past week, the price has changed by +2.03%, over one month by +4.26%, over three months by +13.35% and over the past year by +56.85%.
- StrongBuy: 8
- Buy: 2
- Hold: 14
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 203.3 | 2.8% |
P/E Forward = 16.4745
P/S = 4.0864
P/B = 2.9134
P/EG = 2.3214
Revenue TTM = 120.22b USD
EBIT TTM = 16.41b USD
EBITDA TTM = 27.21b USD
Long Term Debt = 370.53b USD (from longTermDebt, last quarter)
Short Term Debt = 22.67b USD (from shortTermDebt, last quarter)
Debt = 394.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -265.51b USD (recalculated: Debt 394.23b - CCE 659.74b)
Enterprise Value = 33.52b USD (299.02b + Debt 394.23b - CCE 659.74b)
Interest Coverage Ratio = 0.33 (Ebit TTM 16.41b / Interest Expense TTM 50.19b)
EV/FCF = -31.86x (Enterprise Value 33.52b / FCF TTM -1.05b)
FCF Yield = -3.14% (FCF TTM -1.05b / Enterprise Value 33.52b)
FCF Margin = -0.88% (FCF TTM -1.05b / Revenue TTM 120.22b)
Net Margin = 15.13% (Net Income TTM 18.18b / Revenue TTM 120.22b)
Gross Margin = 57.99% ((Revenue TTM 120.22b - Cost of Revenue TTM 50.50b) / Revenue TTM)
Gross Margin QoQ = 61.79% (prev 58.02%)
Tobins Q-Ratio = 0.02 (Enterprise Value 33.52b / Total Assets 1581.42b)
Interest Expense / Debt = 3.19% (Interest Expense 12.57b / Debt 394.23b)
Taxrate = 19.58% (1.37b / 7.01b)
NOPAT = 13.20b (EBIT 16.41b * (1 - 19.58%))
Current Ratio = 1.61 (Total Current Assets 1075.79b / Total Current Liabilities 666.50b)
Debt / Equity = 3.45 (Debt 394.23b / totalStockholderEquity, last quarter 114.29b)
Debt / EBITDA = -9.76 (Net Debt -265.51b / EBITDA 27.21b)
Debt / FCF = 252.4 (negative FCF - burning cash) (Net Debt -265.51b / FCF TTM -1.05b)
Total Stockholder Equity = 111.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.26% (Net Income 18.18b / Total Assets 1581.42b)
RoE = 16.38% (Net Income TTM 18.18b / Total Stockholder Equity 111.02b)
RoCE = 3.41% (EBIT 16.41b / Capital Employed (Equity 111.02b + L.T.Debt 370.53b))
RoIC = 2.81% (NOPAT 13.20b / Invested Capital 468.82b)
WACC = 6.38% (E(299.02b)/V(693.26b) * Re(11.41%) + D(394.23b)/V(693.26b) * Rd(3.19%) * (1-Tc(0.20)))
Discount Rate = 11.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.09 | Cagr: -0.93%
[DCF] Fair Price = unknown (Cash Flow -1.05b)
EPS Correlation: 97.06 | EPS CAGR: 33.00% | SUE: 2.15 | # QB: 3
Revenue Correlation: 98.04 | Revenue CAGR: 15.39% | SUE: 0.91 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.76 | Chg30d=-0.26% | Revisions=+44% | Analysts=14
EPS next Quarter (2026-09-30): EPS=2.90 | Chg30d=-0.60% | Revisions=+0% | Analysts=14
EPS current Year (2026-12-31): EPS=11.84 | Chg30d=+0.37% | Revisions=+74% | GrowthEPS=+16.0% | GrowthRev=+9.6%
EPS next Year (2027-12-31): EPS=12.69 | Chg30d=+0.40% | Revisions=+74% | GrowthEPS=+7.1% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: +74%